ETIVELCABTAGENE ERIGEDLEUCEL
UNII E4X5PXM3XS

Substance Identification & Data

This profile provides standardized clinical and technical data for Etivelcabtagene Erigedleucel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E4X5PXM3XS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E4X5PXM3XS

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ETIVELCABTAGENE ERIGEDLEUCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13171

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-223

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Etivelcabtagene Erigedleucel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ETIVELCABTAGENE ERIGEDLEUCEL

Common Names & Synonyms

ETIVELCABTAGENE ERIGEDLEUCEL [USAN]

UCART20X22 IS DEFINED AS ALLOGENEIC, NON-ALLOREACTIVE T-CELLS, TRANSDUCED WITH A SELF-INACTIVATING (SIN) RECOMBINANT LENTIVIRAL VECTOR TO EXPRESS TWO CHIMERIC ANTIGEN RECEPTOR (CAR) CONSTRUCTS, EACH OF THEM DIRECTED AGAINST CLUSTER OF DIFFERENTIATION (CD)20 OR CD22, AND GENETICALLY EDITED WITH TALEN? (TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES) TO DISRUPT THE CD52 AND THE T CELL RECEPTOR ALPHA CONSTANT (TRAC) GENES

Technical Codes

UCART20X22

External Clinical & Regulatory Resources

Previous UNIIE4X5PVW2TV

Next UNIIE4XEY076JN